J&J says its one-shot Covid-19 vaccine is 72% effective in the U.S.

Johnson & Johnson said its one-dose coronavirus vaccine was 72% reliable in safeguarding versus moderate to severe Covid-19 in the United States. The vaccine was less potent in other regions, according to the business’s trials. CNBC’s Meg Tirrell reports. For access to live and exclusive video from CNBC sign up for CNBC PRO: https://cnb.cx/2NGeIvi
.Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the current stock exchange news and analysis. From market futures to live rate updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s everyday news podcast supplying deep, non-partisan coverage and viewpoint on the day’s most important stories. Offered to listen by 8: 30 pm ET/ 5: 30 pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/ the-news-with-shepard-smith-podcast. html? __ source= youtube% 7Cshepsmith% 7Cpodcast
.
Get In Touch With CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/
.
#CNBC
#CNBCTV.

https://covid19globalcases.com/jj-says-its-one-shot-covid-19-vaccine-is-72-effective-in-the-u-s/